参考文献:
[1]S.K. Sonkusare, C.L. Kaul, P. Ramarao Dementia of Alzheimer’s disease and other neurodegenerative disorders - Memantine, a new hope Pharmacol. Res., 51 (2005), pp. 1-17
[2]追寻阿尔兹海默博士足迹:http://blog.sciencenet.cn/blog-393255-602560.html
[3]S.G. Snowden, A.A. Ebshiana, A. Hye, O. Pletnikova, R. O’Brien, A. Yang, J. Troncoso, C.
Neurotransmitter imbalance in the brain and Alzheimer’s disease pathology Alzheimers Dis., 72 (2019), pp. 35-43
[4]M.P. Mattson Pathways towards and away from Alzheimer’s disease Nature, 430 (2004), pp. 631-639
[5]J. Wang, B.J. Gu, C.L. Masters, Y.J. Wang A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain Nat. Rev. Neurol., 13 (2017), pp. 612-623
[6]C. Pereira, P. Agostinho, P.I. Moreira, S.M. Cardoso, C.R. Oliveira Alzheimer’s disease-associated neurotoxic mechanisms and neuroprotective strategies Curr. Drug Targets CNS Neurol. Disord., 4 (2005), pp. 383-403
[7]J. Godyń, J. Jończyk, D. Panek, B. Malawska Therapeutic strategies for Alzheimer’s disease in clinical trials Pharmacol. Reports., 68 (2016), pp. 127-138
[8]A.A.D.T.AbeysingheabR.D.U.S.DeshapriyaacC.Udawattea Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions